Magnetic resonance imaging in thyroid eye disease: Signal intensity ratio to measure disease activity.
作者信息
Rath Suryasnata
机构信息
L V Prasad Eye Institute, Bhubaneswar, Odisha, India.
出版信息
Indian J Ophthalmol. 2022 May;70(5):1446-1447. doi: 10.4103/ijo.IJO_365_22.
Abstract
摘要
相似文献
1
Magnetic resonance imaging in thyroid eye disease: Signal intensity ratio to measure disease activity.甲状腺眼病的磁共振成像：用于测量疾病活动度的信号强度比
Indian J Ophthalmol. 2022 May;70(5):1446-1447. doi: 10.4103/ijo.IJO_365_22.
2
Ultrasonography compared to magnetic resonance imaging in thyroid-associated Graves' ophthalmopathy.甲状腺相关性格雷夫斯眼病中超声检查与磁共振成像的比较
Arq Bras Endocrinol Metabol. 2011 Apr;55(3):184-8. doi: 10.1590/s0004-27302011000300002.
3
Extrathyroidal manifestations of thyroid disease: thyroid ophthalmopathy.甲状腺疾病的甲状腺外表现：甲状腺眼病。
Neuroimaging Clin N Am. 2008 Aug;18(3):527-36, viii-ix. doi: 10.1016/j.nic.2008.03.003.
4
Triamcinolone for the Treatment of Graves Ophthalmopathy Tested With Short Tau Inversion Recovery Magnetic Resonance.采用短回波时间反转恢复磁共振成像技术检测曲安奈德治疗格雷夫斯眼病
Ophthalmic Plast Reconstr Surg. 2019 Jan/Feb;35(1):22-24. doi: 10.1097/IOP.0000000000001125.
5
Euthyroid Graves' ophthalmopathy with negative autoantibodies.自身抗体阴性的甲状腺功能正常的Graves眼病
J Natl Med Assoc. 2005 Nov;97(11):1547-9.
6
Magnetic Resonance Imaging in the Management of Thyroid Eye Disease: A Systematic Review.磁共振成像在甲状腺眼病管理中的应用：系统评价。
Ophthalmic Plast Reconstr Surg. 2023 Dec 1;39(6S):S81-S91. doi: 10.1097/IOP.0000000000002511. Epub 2023 Dec 4.
7
A Review of Imaging Modalities in Thyroid-associated Orbitopathy.甲状腺相关眼病的影像学检查方法综述
Int Ophthalmol Clin. 2019 Fall;59(4):81-93. doi: 10.1097/IIO.0000000000000289.
8
Correlation of signal intensity ratio on orbital MRI-TIRM and clinical activity score as a possible predictor of therapy response in Graves' orbitopathy--a pilot study at 1.5 T.眼眶 MRI-TIRM 上的信号强度比值与临床活动评分的相关性作为格雷夫斯眼病治疗反应的可能预测指标——1.5T 的初步研究
Neuroradiology. 2010 Feb;52(2):91-7. doi: 10.1007/s00234-009-0590-z. Epub 2009 Sep 15.
9
Thyroid eye disease.甲状腺眼病
QJM. 2016 Jan;109(1):67-8. doi: 10.1093/qjmed/hcv165. Epub 2015 Oct 8.
10
Correlation Between Optical Coherence Tomography and Magnetic Resonance Imaging of Rectus Muscle Thickness Measurements in Graves' Ophthalmopathy.格雷夫斯眼病中直肌厚度测量的光学相干断层扫描与磁共振成像的相关性
J Pediatr Ophthalmol Strabismus. 2019 Sep 1;56(5):319-326. doi: 10.3928/01913913-20190607-01.
引用本文的文献
1
Corneal breakdown in thyroid eye disease: Presentation and outcomes over a decade.甲状腺眼病中的角膜病变：十年间的表现与转归
Indian J Ophthalmol. 2025 Apr 1;73(4):567-576. doi: 10.4103/IJO.IJO_1067_24. Epub 2025 Mar 27.
2
Assessing the relationship between levator palpebrae superioris and thyroid-associated ophthalmopathy using the Dixon-T2WI sequence.使用Dixon-T2WI序列评估提上睑肌与甲状腺相关眼病之间的关系。
Front Endocrinol (Lausanne). 2024 May 28;15:1387217. doi: 10.3389/fendo.2024.1387217. eCollection 2024.
3
Efficacy and Safety of 6-Weekly versus 12-Weekly Intravenous Methylprednisolone in Moderate-to-Severe Active Thyroid-Associated Ophthalmopathy.每6周与每12周静脉注射甲泼尼龙治疗中重度活动性甲状腺相关性眼病的疗效与安全性
J Clin Med. 2023 May 1;12(9):3244. doi: 10.3390/jcm12093244.
本文引用的文献
1
Triamcinolone acetonide injection in the treatment of upper eyelid retraction in Graves' ophthalmopathy evaluated by 3.0 Tesla magnetic resonance imaging.曲安奈德注射液治疗Graves眼病上睑退缩的3.0特斯拉磁共振成像评估
Indian J Ophthalmol. 2022 May;70(5):1736-1741. doi: 10.4103/ijo.IJO_2228_21.
2
The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy.2021 年欧洲 Graves 眼病专家组（EUGOGO）Graves 眼病医学管理临床实践指南。
Eur J Endocrinol. 2021 Aug 27;185(4):G43-G67. doi: 10.1530/EJE-21-0479.
3
Sight-Threatening Thyroid Eye Disease: Role of Diabetes Mellitus and Interaction with Other Risk Factors.威胁视力的甲状腺眼病：糖尿病的作用及与其他危险因素的相互作用。
Ophthalmic Plast Reconstr Surg. 2021;37(4):352-360. doi: 10.1097/IOP.0000000000001871.
4
Use of MRI signal intensity of extraocular muscles to evaluate methylprednisolone pulse therapy in thyroid-associated ophthalmopathy.利用眼外肌的磁共振成像信号强度评估甲基强的松龙脉冲疗法治疗甲状腺相关性眼病的效果。
Jpn J Ophthalmol. 2015 Mar;59(2):124-30. doi: 10.1007/s10384-014-0365-x. Epub 2014 Dec 3.
5
Disease activity in Graves' ophthalmopathy: diagnosis with orbital MR imaging and correlation with clinical score.格雷夫斯眼病的疾病活动度：眼眶磁共振成像诊断及其与临床评分的相关性
Neuroradiol J. 2013 Oct;26(5):555-64. doi: 10.1177/197140091302600509. Epub 2013 Nov 7.
6
Subconjunctival injection of triamcinolone for the treatment of upper lid retraction associated with thyroid eye disease.结膜下注射曲安奈德治疗甲状腺眼病相关的上睑退缩。
J Craniofac Surg. 2012 Nov;23(6):1755-8. doi: 10.1097/SCS.0b013e3182646043.
7
Repeated triamcinolone acetonide injection in the treatment of upper-lid retraction in patients with thyroid-associated ophthalmopathy.重复曲安奈德醋酸酯注射治疗甲状腺相关眼病患者的上睑退缩。
Can J Ophthalmol. 2012 Feb;47(1):34-41. doi: 10.1016/j.jcjo.2011.12.005.
8
Graves' ophthalmopathy.格雷夫斯眼病。
N Engl J Med. 2010 Feb 25;362(8):726-38. doi: 10.1056/NEJMra0905750.
9
Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy.临床活动评分作为格雷夫斯眼病患者管理的指导
Clin Endocrinol (Oxf). 1997 Jul;47(1):9-14. doi: 10.1046/j.1365-2265.1997.2331047.x.
10
Magnetic resonance imaging in thyroid eye disease.甲状腺眼病的磁共振成像
Eye (Lond). 1996;10 ( Pt 5):617-9. doi: 10.1038/eye.1996.140.
Zotero 插件